Intrinsic Value
VistaGen Therapeutics, Inc. (VTGN)
$4.5
+0.09 (+2.04%)
Enterprise Value | - |
---|---|
Net Debt | -13.92 |
Equity Value | - |
Shares Outstanding | 6.96 |
Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt